EDITORIAL

1. Checkpoint inhibitor-induced hepatotoxicity: Role of liver biopsy and management approach

REVIEW

1. Gut microbiota contribution to hepatocellular carcinoma manifestation in non-alcoholic steatohepatitis
2. Hepatogenous diabetes: Knowledge, evidence, and skepticism
3. Small extracellular vesicles and liver diseases: From diagnosis to therapy

ORIGINAL ARTICLE

1. Hepatocellular carcinoma and microbiota: lmplications for clinical management and treatment
2. Tissue pad degradation of ultrasonic device may enhance thermal injury and impair its sealing performance in liver surgery
3. Regulation of PPAR-γ activity in lipid-laden hepatocytes affects macrophage polarization and inflammation in nonalcoholic fatty liver disease
4. Transcriptome changes in stages of non-alcoholic fatty liver disease
5. Cardiac risk factors limiting survival to liver transplantation in patients with nonalcoholic fatty liver disease
6. Differential distribution of gene polymorphisms associated with hypercholesterolemia, hypertriglyceridemia, and hypoalphalipoproteinemia among Native American and Mestizo Mexicans
7. Effect of thrombocytopenia and platelet transfusion on outcomes of acute variceal bleeding in patients with chronic liver disease
8. Polymorphism AGT2 (rs4762) is involved in the development of dermatologic events: Proof-of-concept in hepatocellular carcinoma patients treated with sorafenib
9. Hepatobiliary phases in magnetic resonance imaging using liverspecific contrast for focal lesions in clinical practice
10. Efficacy and safety of COVlD-19 vaccination in patients with cirrhosis
11. Pre-sarcopenia and Mac-2 binding protein glycosylation isomer as predictors of recurrence and prognosis of early-stage hepatocellular carcinoma
12. Hepatitis C virus burden: Treating and educating people without prejudice
13. Volumetric assessment of hepatic grafts using a light detection and ranging system for 3D scanning: Preliminary data

MINIREVIEWS

1. Challenge of managing hepatitis B virus and hepatitis C virus infections in resource-limited settings
2. Alfapump® implantable device in management of refractory ascites:An update

CASE REPORT

1. Hepatitis B virus markers in hepatitis B surface antigen negative patients with pancreatic cancer: Two case reports
2. “Starry liver” - Von Meyenburg complex clinical case presentation and differential diagnosis discussion: A case report

RETRACTION NOTE

1. Retraction Note: Screening and identification of bioactive compounds from citrus against non-structural protein 3 protease of hepatitis C virus genotype 3a by fluorescence resonance energy transfer assay and mass spectrometry